DESMOPRESSIN ACETATE

UBI Pharma Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 16, 2023
Approval ID: b2fad59d-6176-4e09-9fbb-5cdd7f8f1568
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DESMOPRESSIN ACETATE INJECTION USP safely and effectively. See full prescribing information for DESMOPRESSIN ACETATE INJECTION USP. DESMOPRESSIN ACETATE injection, for intravenous or subcutaneous use Initial U.S. Approval: 1978

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.